Ontology highlight
ABSTRACT: Hepatic fibrosis decreased feces bile acid level. Hepatic fibrosis increased serum bile acid. This result showed that hepatic fibrosis inhibited the excretion of bile acid in clinical patients. This result provided phenotype for hepatic fibrosis patients. Bile acid was important indexes for liver injury. TCDCA was important, and it play toxicity effect through ferroptosis and apoptosis. The research for other bile acid such CA, UDCA, TUDCA, TDCA, LCA, TLCA would be important. Hepatic fibrosis serum (sample 1) analysis is reported in the current study MTBLS6732. Hepatic fibrosis feces (sample 2) analysis is reported in MTBLS6742. Hepatic fibrosis serum+feces (sample 3) analysis is reported in MTBLS6728.
INSTRUMENT(S): Liquid Chromatography MS - negative - reverse phase, Liquid Chromatography MS - positive - reverse phase
PROVIDER: MTBLS6732 | MetaboLights | 2023-03-17
REPOSITORIES: MetaboLights
| Action | DRS | |||
|---|---|---|---|---|
| 1_c10_esi-.d.zip | Other | |||
| 1_c11_esi-.d.zip | Other | |||
| 1_c12_esi-.d.zip | Other | |||
| 1_c13_esi-.d.zip | Other | |||
| 1_c14_esi-.d.zip | Other |
Items per page: 5 1 - 5 of 179 |

Zhao Qi Q Dai Man-Yun MY Huang Ruo-Yue RY Duan Jing-Yi JY Zhang Ting T Bao Wei-Min WM Zhang Jing-Yi JY Gui Shao-Qiang SQ Xia Shu-Min SM Dai Cong-Ting CT Tang Ying-Mei YM Gonzalez Frank J FJ Li Fei F
Nature communications 20230401 1
Parabacteroides distasonis (P. distasonis) plays an important role in human health, including diabetes, colorectal cancer and inflammatory bowel disease. Here, we show that P. distasonis is decreased in patients with hepatic fibrosis, and that administration of P. distasonis to male mice improves thioacetamide (TAA)- and methionine and choline-deficient (MCD) diet-induced hepatic fibrosis. Administration of P. distasonis also leads to increased bile salt hydrolase (BSH) activity, inhibition of i ...[more]